Testing Pooled Specimens With the Abbott Alinity m STI Assay: Four Years' Experience
- PMID: 40672015
- PMCID: PMC12265843
- DOI: 10.7759/cureus.86110
Testing Pooled Specimens With the Abbott Alinity m STI Assay: Four Years' Experience
Abstract
Background: The Alinity m STI assay (Abbott Molecular, Des Plaines, IL, USA) is designed for the qualitative detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma genitalium (MG), and Trichomonas vaginalis (TV) in individual collected samples. Pooled specimens are not recommended due to the high risk of inhibition.
Methods: We performed a two-part study, including a preliminary validation on 13 well-known positive samples before and after pooling, as well as a retrospective analysis of 5324 pooled specimens collected between 2021 and 2024. All samples were tested for CT/NG detection, and a subset (n = 277) for MG detection on the Alinity m STI system.
Results: The preliminary validation showed consistent results without inhibition. Out of 5324 specimens of the retrospective analysis for CT/NG detection, 966 pooled samples (18.1%) were positive: 363 (6.8%) for CT, 479 (9.0%) for NG, and 124 (2.3%) for both CT and NG. Only 95 (1.8%) tests were completely inhibited. A total of 277 specimens were additionally tested for MG. Pooled specimens also allowed MG detection (n = 195; 70.4%) with few inhibited results (n = 3; 1.0%).
Conclusions: This study proves that pooled specimens are rarely inhibited and can be helpful for laboratories where the number of specimens per patient is restricted.
Keywords: chlamydia trachomatis; inhibition; mycoplasma genitalium; neisseria gonorrhoeae; pooled specimens.
Copyright © 2025, Argudín et al.
Conflict of interest statement
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Comité d'Ethique Hospitalo-Facultaire Saint-Luc – UCL issued approval 2025/09MAR/104. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Similar articles
-
Clinical Evaluation of the Alinity m STI Multiplex PCR Assay.Sex Transm Dis. 2024 Jul 1;51(7):480-485. doi: 10.1097/OLQ.0000000000001964. Epub 2024 Mar 4. Sex Transm Dis. 2024. PMID: 38465972
-
Clinical evaluation of two commercial PCR kits for the detection of nonviral sexually transmitted infections.J Med Microbiol. 2025 Jul;74(7):002037. doi: 10.1099/jmm.0.002037. J Med Microbiol. 2025. PMID: 40605691 Free PMC article.
-
Extragenital self-collection testing for gonorrhea and chlamydia: A feasibility study for expanding STI screening in the Veterans Health Administration.Am J Clin Pathol. 2025 Mar 8;163(3):406-410. doi: 10.1093/ajcp/aqae135. Am J Clin Pathol. 2025. PMID: 39394953
-
Home-based versus clinic-based specimen collection in the management of Chlamydia trachomatis and Neisseria gonorrhoeae infections.Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD011317. doi: 10.1002/14651858.CD011317.pub2. Cochrane Database Syst Rev. 2015. PMID: 26418128 Free PMC article.
-
Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 Jan 15;1:CD012768. doi: 10.1002/14651858.CD012768.pub3. PMID: 30148542 Free PMC article. Updated.
References
-
- Abbott Molecular Inc. Abbott Molecular Inc. Alinity m STI assay. Reference 09N17-090. Package insert 53-608076/R6. 2020. https://www.molecular.abbott/int/en/products/infectious-disease/alinity-... https://www.molecular.abbott/int/en/products/infectious-disease/alinity-...
-
- Abbott Molecular Inc. 2021. Abbott Molecular Inc. Alinity m STI assay. Reference 09N17-091. Package insert 53-608221/R1. 2021. https://www.molecular.abbott/int/en/products/infectious-disease/alinity-... https://www.molecular.abbott/int/en/products/infectious-disease/alinity-...
-
- The diagnostic accuracy of pooled testing from multiple individuals for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review. Xu Y, Aboud L, Chow EP, et al. Int J Infect Dis. 2022;118:183–193. - PubMed
-
- Abbott Molecular Inc. 2010. Abbott RealTime CT/NG. Abbott Molecular Inc. Abbott RealTime CT/NG. Reference 8L07-91. Package insert 51-608362/R1. 2010. https://www.molecular.abbott/content/dam/add/molecular/products/pdf-/ctn... https://www.molecular.abbott/content/dam/add/molecular/products/pdf-/ctn...
LinkOut - more resources
Full Text Sources